View Item 

Show simple item record

Mitral valve repair in heart failure

dc.contributor.authorSmolens, Iva A.en_US
dc.contributor.authorPagani, Francis D.en_US
dc.contributor.authorBolling, Steven F.en_US
dc.date.accessioned2014-02-11T17:56:58Z
dc.date.available2014-02-11T17:56:58Z
dc.date.issued2000-12en_US
dc.identifier.citationSmolens, Iva A.; Pagani, Francis D.; Bolling, Steven F. (2000). "Mitral valve repair in heart failure." European Journal of Heart Failure 2(4): 365-371. <http://hdl.handle.net/2027.42/102643>en_US
dc.identifier.issn1388-9842en_US
dc.identifier.issn1879-0844en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/102643
dc.description.abstractMitral regurgitation (MR) is a frequent complication of end‐stage heart failure. Historically, these patients were either managed medically or with mitral valve replacement, both associated with poor outcomes. Mitral valve repair via an ‘undersized’ annuloplasty repair is safe and effectively corrects MR in heart‐failure patients. All of the observed changes contribute to reverse remodeling and restoration of the normal left‐ventricular geometric relationship. Mitral valve repair offers a new strategy for patients with MR and end‐stage heart failure.en_US
dc.publisherFuturaen_US
dc.publisherWiley Periodicals, Inc.en_US
dc.subject.otherAnnuloplastyen_US
dc.subject.otherMitral Valve Repairen_US
dc.subject.otherMitral Regurgitation (MR)en_US
dc.titleMitral valve repair in heart failureen_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelCardiovascular Medicineen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.identifier.pmid11113712en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/102643/1/ejhf00125-2.pdf
dc.identifier.doi10.1016/S1388-9842(00)00125-2en_US
dc.identifier.sourceEuropean Journal of Heart Failureen_US
dc.identifier.citedreferenceAnguita M. Arizon J.M. Bueno G. et al. Clinical and hemodynamic predictors of survival in patients aged <65 years with severe congestive heart failure secondary to ischemic or non‐ischemic dilated heart failure Am J Cardiol 1993 72 5 413 417en_US
dc.identifier.citedreferenceTorre‐Amione G. The syndrome of heart failure: emerging concepts in the understanding of its pathogenesis and treatment Curr Opin Cardiol 1999 14 193 195en_US
dc.identifier.citedreferenceBohm M. Alterations of beta‐adrenoceptor‐G‐protein‐regulated adenylyl cyclase in heart failure Mol Cell Biochem 1995 147 1‐2 147 160en_US
dc.identifier.citedreferenceBohm M. Diet F. Kemkes B. Erdmann E. Enhancement of the effectiveness of milrinone to increase force of contraction by stimulation of cardiac beta‐adrenoceptors in the failing human heart Klin Wochenschrift 1988 66 19 957 962en_US
dc.identifier.citedreferenceFeldman M.D. Copelas L. Gwathmey J.K. et al. Deficient production of cyclic AMP: pharmacologic evidence of an important cause of contractile dysfunction in patients with end‐stage heart failure Circulation 1987 75 2 331 339en_US
dc.identifier.citedreferenceJuilliere Y. Danchin N. Briancon S. et al. Dilated heart failure: long‐term follow‐up and predictors of survival Int J Cardiol 1988 21 3 269 277en_US
dc.identifier.citedreferenceChandraratna P.A. Aronow W.S. Mitral valve ring in normal vs. dilated left ventricle. Cross‐sectional echocardiographic study Chest 1981 79 2 151 154en_US
dc.identifier.citedreferenceKay G.L. Kay J.H. Zubiate P. Yokoyama T. Mendez M. Mitral valve repair for mitral regurgitation secondary to coronary artery disease Circulation 1986 74 3 part 2 I88 98en_US
dc.identifier.citedreferenceRosario L.B. Stevenson L.W. Solomon S.D. Lee R.T. Reimold S.C. The mechanism of decrease in dynamic mitral regurgitation during heart failure treatment: importance of reduction in the regurgitant orifice size J Am Coll Cardiol 1998 32 1819 1824en_US
dc.identifier.citedreferenceFann J.I. Ingels N.B. Miller D.C. Edmunds L.H. Pathophysiology of mitral valve disease and operative indications Cardiac Surgery in the Adult 1997 NY McGraw‐Hill 959 990en_US
dc.identifier.citedreferenceAkasaka T. Yoshida K. Hozumi T. et al. Restricted coronary flow reserve in patients with mitral regurgitation improves after mitral reconstructive surgery J Am Coll Cardiol 1998 32 1923 1930en_US
dc.identifier.citedreferencePagani F.D. Baker L.S. Hsi C. Knox M. Fink M.P. Visner M.S. Left ventricular systolic and diastolic dysfunction after infusion of tumor necrosis factor‐α in conscious dogs J Clin Invest 1992 90 389 398en_US
dc.identifier.citedreferenceBlum A. Miller H. Role of cytokines in heart failure Am Heart J 1998 135 2 part 1 181 186en_US
dc.identifier.citedreferenceTorre‐Amione G. Kapadia S. Benedict C. Oral H. Young J.B. Mann D.L. Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: a report from the studies of left ventricular dysfunction (SOLVD) J Am Coll Cardiol 1996 27 5 1201 1206en_US
dc.identifier.citedreferenceLevine B. Kalman J. Mayer L. Fillit H.M. Packer M. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure N Engl J Med 1990 323 236 241en_US
dc.identifier.citedreferenceHerrera‐Garza E.H. Stetson S.J. Cubillos‐Garzon A. Vooletich M.T. Farmer J.A. Torre‐Amione G. Tumor necrosis factor‐α: a mediator of disease progression in the failing human heart Chest 1999 115 1170 1174en_US
dc.identifier.citedreferenceSuffredini A.F. Fromm R.E. Parker M.M. et al. The cardiovascular response of normal humans to the administration of endotoxin N Engl J Med 1989 321 26 1828 1830en_US
dc.identifier.citedreferenceHagewisch S. Weh H.J. Hossfeld D.K. TNF‐induced heart failure Lancet 1990 335 8684 294 295en_US
dc.identifier.citedreferenceMilani R.V. Mehra M.R. Endres S. et al. The clinical relevance of circulating tumor necrosis factor‐alpha in acute decompensated chronic heart failure without cachexia Chest 1996 110 4 992 995en_US
dc.identifier.citedreferenceTorre‐Amione G. Kapadia S. Lee J. et al. Tumor necrosis factor‐alpha and tumor necrosis factor receptors in the failing human heart Circulation 1996 93 4 704 711en_US
dc.identifier.citedreferenceTavazzi L. Epidemiology of dilated heart failure: a still undetermined entity Eur Heart J 1997 18 1 4 6en_US
dc.identifier.citedreferenceHunt S.A. Current status of cardiac transplantation J Am Med Assoc 1998 280 19 1692 1698en_US
dc.identifier.citedreferenceMagovern J.A. Magovern G.J. Maher T.D. et al. Operation for congestive heart failure: transplantation, coronary artery bypass, and cardiomyoplasty Ann Thorac Surg 1993 56 418 425en_US
dc.identifier.citedreferenceDreyfus G.D. Duboc D. Blasco A. et al. Myocardial viability assessment in ischemic heart failure: benefits of coronary revascularization Ann Thorac Surg 1994 57 1402 1408en_US
dc.identifier.citedreferenceFrazier O.H. First use of an untethered, vented electric left ventricular assist device for long‐term support Circulation 1994 89 6 2908 2914en_US
dc.identifier.citedreferencePennington D.G. Swartz M.T. Lohmann D.P. McBride L.R. Cardiac assist devices Surg Clin North Am 1998 78 5 691 704en_US
dc.identifier.citedreferenceGoldstein D.J. Oz M.C. Rose E.A. Medical progress: implantable left ventricular assist devices N Engl J Med 1998 339 21 1522 1533en_US
dc.identifier.citedreferenceMoreira L.F.P. Jatene A.D. Carpentier A. Chachques J.C. Grandjean P.A. Cardiomyoplasty in dilated heart failure Cardiomyoplasty 1991 Armonk, NY Futura 171 183en_US
dc.identifier.citedreferenceBatista R.J. Santos J.L. Takeshita N. Bocchino L. Lima P.N. Cunha M.A. Partial left ventriculectomy to improve left ventricular function in end‐stage heart disease J Cardiac Surg 1996 11 2 96 97en_US
dc.identifier.citedreferenceBatista R. Partial left ventriculectomy — the Batista procedure Eur J Cardio‐Thorac Surg 1999 15 suppl.1 S12 S19en_US
dc.identifier.citedreferenceBach D.S. Bolling S.F. Early improvement in heart failure after correction of secondary mitral regurgitation in end‐stage heart failure Am Heart J 1995 129 1165 1170en_US
dc.identifier.citedreferenceBolling S.F. Deeb G.M. Brunsting L.A. Bach D.S. Early outcome of mitral valve reconstruction in patients with end‐stage heart failure J Thorac Cardiovasc Surg 1995 109 4 676 683en_US
dc.identifier.citedreferenceBach D.S. Bolling S.F. Improvement following correction of secondary mitral regurgitation in end‐stage heart failure with mitral annuloplasty Am J Cardiol 1996 78 966 969en_US
dc.identifier.citedreferenceBolling S.F. Pagani F.D. Deeb G.M. Bach S.F. Intermediate‐term outcome of mitral reconstruction in heart failure J Thorac Cardiovasc Surg 1998 115 381 388en_US
dc.identifier.citedreferenceChen F.Y. Adams D.H. Aranki S.F. et al. Mitral valve repair in heart failure Circulation 1998 98 II124 II127en_US
dc.identifier.citedreferenceBoltwood C.M. Tei C. Wong M. Shah P.M. Quantitative echocardiography of the mitral complex in dilated heart failure: the mechanism of functional mitral regurgitation Circulation 1983 68 3 498 508en_US
dc.identifier.citedreferenceKono T. Sabbah H.N. Rosman H. Alam M. Jafri S. Goldstein S. Left ventricular shape is the primary determinant of functional mitral regurgitation in heart failure J Am Coll Cardiol 1992 7 20 1594 1598en_US
dc.identifier.citedreferenceIzumi S. Miyatake K. Beppu S. et al. Mechanism of mitral regurgitation in patients with myocardial infarction: a study using real‐time two‐dimensional Doppler flow imaging and echocardiography Circulation 1987 76 4 777 785en_US
dc.identifier.citedreferenceYoran C. Yellin E.L. Becker R.M. Gabbay S. Frater R.W. Sonnenblick E.H. Dynamic aspects of acute mitral regurgitation: effects of ventricular volume, pressure and contractility on the effective regurgitant orifice area Circulation 1979 60 1 170 176en_US
dc.identifier.citedreferenceBlondheim D.S. Jacobs L.E. Kotler M.N. Costacurta G.A. Parry W.R. Dilated heart failure with mitral regurgitation: decreased survival despite a low frequency of left ventricular thrombus Am Heart J 1991 122 3 part 1 763 771en_US
dc.identifier.citedreferenceStevenson L.W. Fowler M.B. Schroeder J.S. Stevenson W.G. Dracup K.A. Fond V. Poor survival of patients with idiopathic heart failure considered too well for transplantation Am J Medicine 1987 83 5 871 876en_US
dc.identifier.citedreferencePitarys C.J.II Forman M.B. Panayiotou H. Hansen D.E. Long‐term effects of excision of the mitral apparatus on global and regional ventricular function in humans J Am Coll Cardiol 1990 15 3 557 563en_US
dc.identifier.citedreferencePinson C.W. Cobanoglu A. Metwdorff M.T. Grunkemeier G.L. Kay P.H. Starr A. Late surgical results for ischemic mitral regurgitation. Role of wall motion score and severity of regurgitation J Thorac Cardiovasc Surg 1984 88 5 part 1 663 672en_US
dc.identifier.citedreferencePhillips H.R. Levine F.H. Carter J.E. et al. Mitral valve replacement for isolated mitral regurgitation: analysis of clinical course and late postoperative left ventricular ejection fraction Am J Cardiol 1981 48 4 647 654en_US
dc.identifier.citedreferenceSarris G.E. Cahill P.D. Hansen D.E. Derby G.C. Miller D.C. Restoration of left ventricular systolic performance after reattachment of the mitral chordae tendinae. The importance of valvular–ventricular interaction J Thorac Cardiovasc Surg 1988 95 6 969 979en_US
dc.identifier.citedreferenceDavid T.E. Uden D.E. Strauss H.D. The importance of the mitral apparatus in left ventricular function after correction of mitral regurgitation Circulation 1983 68 3 part 2 II76 II82en_US
dc.identifier.citedreferenceHuikuri H.V. Effect of mitral valve replacement on left ventricular function in mitral regurgitation Br Heart J 1983 49 4 328 333en_US
dc.identifier.citedreferenceSchuler G. Peterson K.L. Johnson A. et al. Temporal response of left ventricular performance to mitral valve surgery Circulation 1979 59 6 1218 1231en_US
dc.identifier.citedreferenceGoldman M.E. Mora F. Guarino T. Fuster V. Mindich B.P. Mitral valvuloplasty is superior to valve replacement for preservation of left ventricular function: an intraoperative two‐dimensional echocardiographic study J Am Coll Cardiol 1987 10 3 568 575en_US
dc.identifier.citedreferenceTischler M.D. Cooper K.A. Rowen M. LeWinter M.M. Myocardial function/valvular heart disease/hypertensive heart disease: mitral valve replacement versus mitral valve repair: a Doppler and quantitative stress echocardiographic study Circulation 1994 89 1 132 137en_US
dc.identifier.citedreferenceGallino A. Jenni R. Hurni R. et al. Early results after mitral valvuloplasty for pure mitral regurgitation Eur Heart J 1987 8 8 902 905en_US
dc.identifier.citedreferenceRankin J.S. Feneley M.P. Hickey M.S. et al. A clinical comparison of mitral valve repair versus replacement in ischemic mitral regurgitation J Thorac Cardiovasc Surg 1988 95 2 165 177en_US
dc.identifier.citedreferenceAkins C.W. Hilgenberg A.D. Buckley M.J. et al. Mitral valve reconstruction versus replacement for degenerative or ischemic mitral regurgitation Ann Thorac Surg 1994 58 668 676en_US
dc.identifier.citedreferenceKawaguchi H.K. Kitabatake A. Alterations of signal transduction system in heart failure Jpn Heart J 1997 38 317 332en_US
dc.identifier.citedreferenceBohm M. Catecholamine refractoriness and their mechanisms in cardiocirculatory shock and chronic heart failure Thorac Cardiovasc Surg 1998 46 suppl 270 276en_US
dc.identifier.citedreferenceBristow M.R. Ginsburg R. Minobe W. et al. Decreased catecholamine sensitivity and beta‐adrenergic receptor density in failing human hearts N Engl J Med. 1982 307 205 211en_US
dc.identifier.citedreferenceBrodde O.E. Beta 1‐ and Beta 2‐adrenoceptors in the human heart: properties, function, and alterations in chronic heart failure Pharmacol Rev. 1991 43 2 203 242en_US
dc.identifier.citedreferenceHarding S.E. Brown L.A. Wynne D.G. Davies C.H. Poole‐Wilson P.A. Mechanisms of β adrenoceptor desensitization in the failing human heart Cardiovasc Res 1994 28 1451 1460en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
ejhf00125-2.pdf
Size:
93.23KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.